Janet Reno “showed the world that Parkinson’s does not have to define you”

Perspectives

Author: Geoffrey ChangPublished: 8 November 2016

Prep: Cook: Serves:

Campaigners celebrate the life of Janet Reno, former US Attorney General, who died after living with Parkinson’s for more than 20 years

Janet Reno, former US Attorney General under President Bill Clinton, died on Monday at the age of 78 after complications with Parkinson’s disease.

Parkinson’s campaigners paid tribute to her as a “legend” for her contribution the Parkinson’s community. She was honorary chair of Moving Day Miami, the National Parkinson Foundation’s fundraising walk, from 2012-2015, and a prominent advocate of Parkinson’s research and awareness.

As the first female Attorney General of the US, Reno served in the Clinton administration from 1993 to 2001. She was diagnosed with Parkinson’s in 1995 after noticing a tremor in her left hand, but continued in her government role.

John Kozyak, chairman of the Parkinson’s Foundation, praised the example she set for others living with the condition: “She set an example for people living with Parkinson’s and she set an example for so many more to live life to the fullest, to be humble and to do the right thing. I will never forget how Janet comforted me when my parents were diagnosed with Parkinson’s. She is a legend to me and many.”

Dr Michael Okun, national medical director of the Parkinson’s Foundation and professor and chairman of neurology at the University of Florida, paid tribute to Reno’s determination to not let the disease define her.

“Janet Reno lived two decades with Parkinson’s and was an amazing example to everyone suffering with this disease, showing that it is possible to live a happy life. She showed the world that Parkinson’s does not have to define you,” said Dr Okun.

Janet Reno at the National Parkinson Foundation event, Moving Day Miami

Image credit: National Parkinson Foundation

Last Month

Next Month

Go Back

Share this story

Comments

rempat

While Parkinson’s doesn’t define us, we cannot ignore it either. I’m glad that Reno sought to comfort others about it, as illustrated in this article. I look at it as an opportunity to gain further experience with it that I can use together with my other skills to help others.
Mary Spremulli,MA,CCC-SLP

When to share the diagnosis has been a topic of discussion with my LOUD Crowd members lately. Saying the PD word out loud let’s the steam out for some people, and others keep it private for longer. Treating PD like a chronic disease, much the way we think of diabetes, can keep it in perspective. Something to be managed, but also only one aspect of all that you are.

Advances

This innovative walking stick may change the lives of Parkinson’s patients

Student receives £15,000 grant to develop smart walking stick

Parkinson’s podcast: Genetics and Parkinson’s disease

Will genetics help us crack the Parkinson's code?

Advanced Parkinson’s: a survivor’s guide to ‘transcending the pain of death’

Book review: ‘Love’s Last Measure’ by Anne Mikkelsen

New award in honour of Tom Isaacs

A new award has been set up in memory of Tom Isaacs, the internationally acclaimed Parkinson’s campaigner who died in May. The annual award by the Van Andel Research Institute and The Cure Parkinson’s Trust will be presented at the Rallying to the Challenge meeting in Michigan, US, later this month. The accolade has been created in recognition of Tom Isaacs’ long-term vision that working with people living with Parkinson’s is essential in the quest for a cure. The award will be given to the researcher whose work has had the greatest impact on the lives of people with Parkinson’s that year. Hundreds of people attended an event held in London, UK, this week held by The Cure Parkinson’s Trust to celebrate the life of Tom Isaacs. The charity’s chief operating officer Helen Matthews thanked Tom for “15 years of inspiration, adventure and fun”.

Learn more

Study suggests telemedicine “as effective as in-person care” for Parkinson’s

A study, published in the journal ‘Neurology’, has found evidence to suggest that telemedicine is just as effective as in-person care for Parkinson’s disease. Researchers found that telemedicine – the ‘virtual’ diagnosis and treatment of individuals through telecommunication technology – can deliver high quality care for those who do not have access to a neurologist. Ray Dorsey, professor of neurology at the University of Rochester Medical Center in New York State, US, and lead author of the study said: “We now have the ability to reach anyone, anywhere, but the promise and benefits of telemedicine will not be fully realised until the changes are made in medicare policy.” The study – which is the first national randomised controlled clinical trial of telemedicine for Parkinson’s disease – was conducted as part of the Connect.Parkinson project, an initiative led by the University of Rochester Medical Center, in collaboration with several other Parkinson’s…

AstraZeneca to receive up to $400 million to co-develop Parkinson’s drug

AstraZeneca is to receive up to $400 million from Takeda Pharmaceutical after agreeing a deal to co-develop an early-stage medicine for Parkinson’s disease. The drug, MEDI1341, is an antibody treatment and is due to enter phase I clinical trials later this year. Mene Pangalos, executive vice president of AstraZeneca, said: “By combining our scientific expertise and sharing the risks and cost of development, we hope to accelerate the advancement of MEDI1341 as a promising new approach to support the treatment of people with Parkinson’s disease around the world.” The two companies will share future development and commercialisation costs for MEDI1341 equally, in addition to future revenues.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
Captcha
*
- By proceeding you agree to our
Phone
This field is for validation purposes and should be left unchanged.

Janet Reno “showed the world that Parkinson’s does not have to define you”

Perspectives

Author: Geoffrey ChangPublished: 8 November 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Advances

This innovative walking stick may change the lives of Parkinson’s patients

Resources & Tools

Parkinson’s podcast: Genetics and Parkinson’s disease

Carers' Corner

Advanced Parkinson’s: a survivor’s guide to ‘transcending the pain of death’

New award in honour of Tom Isaacs

Study suggests telemedicine “as effective as in-person care” for Parkinson’s

AstraZeneca to receive up to $400 million to co-develop Parkinson’s drug

{title}

Subscribe

Janet Reno “showed the world that Parkinson’s does not have to define you”

Perspectives

Author: Geoffrey ChangPublished: 8 November 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Advances

This innovative walking stick may change the lives of Parkinson’s patients

Resources & Tools

Parkinson’s podcast: Genetics and Parkinson’s disease

Carers' Corner

Advanced Parkinson’s: a survivor’s guide to ‘transcending the pain of death’

New award in honour of Tom Isaacs

Study suggests telemedicine “as effective as in-person care” for Parkinson’s

AstraZeneca to receive up to $400 million to co-develop Parkinson’s drug

{title}

Subscribe

Sign in